These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29122485)

  • 1. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
    Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
    J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
    Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
    Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).
    Homma A; Nakamura K; Matsuura K; Mizusawa J; Onimaru R; Fukuda H; Fujii M
    Jpn J Clin Oncol; 2015 Jan; 45(1):119-22. PubMed ID: 25332419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-treatment magnetic resonance imaging predicts outcomes of maxillary sinus cancer treatment using super-selective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT).
    Yamauchi H; Baba A; Ogino N; Matsushima S; Ashida H; Nagaoka M; Ojiri H
    Auris Nasus Larynx; 2024 Aug; 51(4):631-635. PubMed ID: 38626697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
    Homma A; Mikami M; Matsuura K; Onimaru R; Yoshida D; Shinomiya H; Ohkoshi A; Hayashi R; Saito Y; Tachibana H; Shiga K; Ueda T; Uemura H; Nakamura K; Fukuda H;
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1271-1281. PubMed ID: 38008195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma.
    Shiga K; Yokoyama J; Hashimoto S; Saijo S; Tateda M; Ogawa T; Watanabe M; Kobayashi T
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):1003-9. PubMed ID: 17547996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
    Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
    Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
    Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
    Kano S; Suzuki T; Yoshida D; Tsushima N; Hamada S; Yasuda K; Uchinami Y; Aoyama H; Homma A
    Int J Clin Oncol; 2023 Sep; 28(9):1121-1128. PubMed ID: 37289379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
    Ebara T; Ando K; Eishima J; Suzuki M; Kawakami T; Horikoshi H; Tamaki Y
    Jpn J Radiol; 2019 Jun; 37(6):494-499. PubMed ID: 30915648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma.
    Ackerstaff AH; Tan IB; Rasch CR; Balm AJ; Keus RB; Schornagel JH; Hilgers FJ
    Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1185-90. PubMed ID: 12365891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus.
    Nibu K; Sugasawa M; Asai M; Ichimura K; Mochiki M; Terahara A; Kawahara N; Asato H
    Cancer; 2002 Mar; 94(5):1476-82. PubMed ID: 11920504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological evaluation of radiotherapy and concomitant intraarterial cisplatin for maxillary sinus cancer.
    Makino T; Tachibana T; Kariya S; Matsui Y; Matsuzaki H; Fujimoto S; Orita Y; Katsui K; Hiraki T; Sato Y; Kanazawa S; Nishizaki K
    Auris Nasus Larynx; 2020 Oct; 47(5):881-886. PubMed ID: 32359864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy.
    Tsushima N; Kano S; Suzuki T; Idogawa H; Yoshida D; Yasuda K; Otsuka M; Aoyama H; Homma A
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):899-905. PubMed ID: 33866400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.
    Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2767-70. PubMed ID: 24213278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemotherapy and radiation therapy for squamous cell carcinoma of the maxillary sinus.
    Isobe K; Uno T; Hanazawa T; Kawakami H; Yamamoto S; Suzuki H; Iida Y; Ueno N; Okamoto Y; Ito H
    Jpn J Clin Oncol; 2005 Nov; 35(11):633-8. PubMed ID: 16275677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superselective arterial cisplatin infusion with concomitant radiation therapy for base of tongue cancer.
    Kano S; Homma A; Oridate N; Suzuki F; Hatakeyama H; Mizumachi T; Furusawa J; Sakashita T; Yoshida D; Onimaru R; Shirato H; Fukuda S
    Oral Oncol; 2011 Jul; 47(7):665-70. PubMed ID: 21576034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-status and an oral fluoropyrimidine, S-1, adjuvant chemotherapy are prognostic factors in reduced-RADPLAT for resectable hypopharyngeal cancer.
    Wakisaka N; Hirai N; Kondo S; Aga M; Nakanishi Y; Tsuji A; Endo K; Murono S; Yoshizaki T
    Acta Otolaryngol; 2016 Aug; 136(8):834-40. PubMed ID: 27007816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase expression as a predictor of clinical response to 5-fluorouracil-based chemoradiotherapy in patients with maxillary sinus squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Yamauchi M; Wakasaki T; Masuda M; Komune S
    Auris Nasus Larynx; 2011 Jun; 38(3):387-91. PubMed ID: 21035287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
    Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.